346 EFFICACY AND SAFETY OF TEVERELIX LA, A NEW GNRH ANTAGONIST IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH). RESULTS FROM A PHASE II RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE, MULTINATIONAL STUDY INVESTIGATING TWO SINGLE INJECTIONS OF 60 MG AT 48 HOURS INTERVAL ADMINISTERED S.C. TO TREATMENT NAÏVE PATIENTS SUFFERING FROM BPH

C. Maclean; F. Larsen; J. Drewe; A.V. Dzmitryieu; A. Gres; A. Strockyi; V. Dovger; A. Ulys; A. Cerniauskienè; P. Geavlete; M. Nikolovski

doi:10.1016/s1569-9056(07)60345-5

346 EFFICACY AND SAFETY OF TEVERELIX LA, A NEW GNRH ANTAGONIST IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH). RESULTS FROM A PHASE II RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE, MULTINATIONAL STUDY INVESTIGATING TWO SINGLE INJECTIONS OF 60 MG AT 48 HOURS INTERVAL ADMINISTERED S.C. TO TREATMENT NAÏVE PATIENTS SUFFERING FROM BPH

European Urology Supplements ◽

10.1016/s1569-9056(07)60345-5 ◽

2007 ◽

Vol 6 (2) ◽

pp. 109 ◽

Cited By ~ 4

Author(s):

C. Maclean ◽

F. Larsen ◽

J. Drewe ◽

A.V. Dzmitryieu ◽

A. Gres ◽

...

Keyword(s):

Benign Prostatic Hyperplasia ◽

Phase Ii ◽

Gnrh Antagonist ◽

Prostatic Hyperplasia ◽

Multinational Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Treatment Naïve

Download Full-text

EFFICACY AND SAFETY OF TEVERELIX LA, A NEW GNRH ANTAGONIST IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH). RESULTS FROM A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE, MULTINATIONAL STUDY INVESTIGATING TWO SINGLE INJECTIONS OF 30 MG OR 60 MG (SEPARATED BY AT LEAST 12 WEEKS) ADMINISTERED SC TO TREATMENT NAIVE PATIENTS SUFFERING FROM BPH

European Urology Supplements ◽

10.1016/s1569-9056(08)60394-2 ◽

2008 ◽

Vol 7 (3) ◽

pp. 170 ◽

Cited By ~ 2

Author(s):

C.M. Maclean ◽

L. Skillern ◽

F. Larsen ◽

A. Gres ◽

A. Strotski ◽

...

Keyword(s):

Benign Prostatic Hyperplasia ◽

Phase Ii ◽

Gnrh Antagonist ◽

Prostatic Hyperplasia ◽

Multinational Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Treatment Naïve

Download Full-text

Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial

Urology ◽

10.1016/j.urology.2019.02.030 ◽

2019 ◽

Vol 129 ◽

pp. 172-179 ◽

Cited By ~ 3

Author(s):

Zhangqun Ye ◽

Jian Huang ◽

Liqun Zhou ◽

Shan Chen ◽

Zengjun Wang ◽

...

Keyword(s):

Benign Prostatic Hyperplasia ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Serenoa Repens ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of Afalaza in men with symptomatic benign prostatic hyperplasia at risk of progression: a multicenter, double-blind, placebo-controlled, randomized clinical trial

Central European Journal of Urology ◽

10.5173/ceju.2018.1803 ◽

2018 ◽

Vol 71 (4) ◽

Keyword(s):

Clinical Trial ◽

At Risk ◽

Benign Prostatic Hyperplasia ◽

Randomized Clinical Trial ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Double Blind ◽

Symptomatic Benign Prostatic Hyperplasia ◽

Double Blind Placebo ◽

Risk Of Progression

Download Full-text

Mild-to-moderate benign prostatic hyperplasia symptoms: Filling the gap. Efficacy and safety of Afalaza in men with benign prostatic hyperplasia at risk of progression: A multicenter, double-blind, placebo-controlled, randomized clinical trial

European Urology Supplements ◽

10.1016/s1569-9056(19)30186-1 ◽

2019 ◽

Vol 18 (1) ◽

pp. e257

Author(s):

A.Z. Vinarov ◽

D. Pushkar ◽

L. Spivak

Keyword(s):

Clinical Trial ◽

At Risk ◽

Benign Prostatic Hyperplasia ◽

Randomized Clinical Trial ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Risk Of Progression

Download Full-text

336 TADALAFIL 5 MG ONCE DAILY IMPROVES ERECTILE DYSFUNCTION (ED) AND THE SIGNS AND SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA (BPH-LUTS) IN MEN WITH BOTH ED AND BPH-LUTS: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTINATIONAL STUDY

European Urology Supplements ◽

10.1016/s1569-9056(11)60332-1 ◽

2011 ◽

Vol 10 (2) ◽

pp. 123

Author(s):

C.G. Roehrborn ◽

R.B. Egerdie ◽

S. Auerbach ◽

P. Costa ◽

M. Sanchez Garza ◽

...

Keyword(s):

Erectile Dysfunction ◽

Benign Prostatic Hyperplasia ◽

Signs And Symptoms ◽

Prostatic Hyperplasia ◽

Multinational Study ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo

Download Full-text

Efficacy and Safety of a Flaxseed Hull Extract in the Symptomatic Management of Benign Prostatic Hyperplasia: A Parallel, Randomized, Double-Blind, Placebo-Controlled, Pilot Study

Journal of Medicinal Food ◽

10.1089/jmf.2013.3129 ◽

2015 ◽

Vol 18 (2) ◽

pp. 233-240 ◽

Cited By ~ 1

Author(s):

Rudy Simons ◽

Navneet Sonawane ◽

Marian Verbruggen ◽

Jayesh Chaudhary

Keyword(s):

Benign Prostatic Hyperplasia ◽

Pilot Study ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Symptomatic Management ◽

Hull Extract

Download Full-text

PD24-03 EFFICACY AND SAFETY OF AFALAZA IN MEN WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA AT RISK OF PROGRESSION: A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL

The Journal of Urology ◽

10.1097/01.ju.0000555930.36243.a1 ◽

2019 ◽

Vol 201 (Supplement 4) ◽

Author(s):

ANDREY VINAROV* ◽

Dmitriy Pushkar ◽

Leonid Spivak

Keyword(s):

Clinical Trial ◽

At Risk ◽

Benign Prostatic Hyperplasia ◽

Randomized Clinical Trial ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Double Blind ◽

Symptomatic Benign Prostatic Hyperplasia ◽

Double Blind Placebo ◽

Risk Of Progression

Download Full-text

Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study

Diabetologia ◽

10.1007/s00125-021-05460-0 ◽

2021 ◽

Author(s):

Linong Ji ◽

Ying Du ◽

Min Xu ◽

Xiangjun Zhou ◽

Zhaohui Mo ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Phase Ii ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Treatment Naïve

Download Full-text

A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study to evaluate the efficacy and safety of VT‐1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail

British Journal of Dermatology ◽

10.1111/bjd.19224 ◽

2020 ◽

Cited By ~ 1

Author(s):

B. Elewski ◽

S. Brand ◽

T. Degenhardt ◽

S. Curelop ◽

R. Pollak ◽

...

Keyword(s):

Phase Ii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Ranging

Download Full-text

Efficacy and Safety of Lebrikizumab in Severe Uncontrolled Asthma: Results from the Lute and Verse Phase II Randomized, Double-Blind, Placebo-Controlled Trials

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2013.12.1064 ◽

2014 ◽

Vol 133 (2) ◽

pp. AB402 ◽

Cited By ~ 13

Author(s):

Nicola A. Hanania ◽

Michael J. Noonan ◽

Jonathan Corren ◽

Phillip Korenblat ◽

Yanan Zheng ◽

...

Keyword(s):

Phase Ii ◽

Controlled Trials ◽

Efficacy And Safety ◽

Uncontrolled Asthma ◽

Double Blind ◽

Double Blind Placebo

Download Full-text